Macro Bites: Life sciences adapt to a new economic paradigm
Gregory Daco and Ranu Carroll discuss a new economic paradigm, supply chain dynamics, imports of active pharmaceutical ingredients and what we’re hearing from clients.
Watch video
Tectonic shifts in operating environment
Shifting environments: Geopolitics and the US Life Sciences sector
Watch the replay
How smaller, smarter deals will help life sciences shape the future with confidence
Hear from a panel of industry leaders as we explore the findings from our 13th annual EY Firepower Report on life sciences dealmaking and M&A growth strategy.
Tariffs are here: what companies need to do now
Get updates from EY tax and trade professionals for an update on what’s happening in trade, the latest on tariffs and steps companies should consider taking now.
The future state of transfer pricing controversy for life sciences
Key actions that companies can be taking today to navigate a rapidly intensifying global transfer pricing controversy environment more effectively.
Solutions that work in practice, not just on paper
Learn how a pharma company’s growth and operational strategy helped establish a global footprint.
Watch now
Creating new life sciences revenue models
Venture building can help life sciences companies drive innovation in the face of the patent cliff.